Radiosynthesis of [11C]Lu 29-024: A potential radiotracer for 5HT2 receptors PET studies

Nuclear Medicine and Biology

Volumn 25, Issue 6, 1998, Pages 517-522

  Amokhtari, Mostafa ^a   Andersen, Kim ^b   Ibazizene, Meziane ^a   Dhilly, Martine ^a   Dauphin, François ^a   Barre, Louisa ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b H LUNDBECK A S   (Denmark)

Author keywords

5HT2 receptor; Carbon 11; PET; Radiotracer; Rat

Indexed keywords

2,5 DIMETHYL 3 (4 FLUOROPHENYL) 1 (1 METHYL 4 PIPERIDINYL) 1H INDOLE C 11; LU 29 024; METHYL IODIDE; RADIOPHARMACEUTICAL AGENT; SEROTONIN 2 RECEPTOR; UNCLASSIFIED DRUG; CARBON; DIAGNOSTIC AGENT; INDOLE DERIVATIVE; IODINATED HYDROCARBON; LU29 024; LU29-024; PIPERIDINE DERIVATIVE; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG METABOLISM; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; ANIMAL; BLOOD; BRAIN; CHEMISTRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MALE; METABOLISM; SCINTISCANNING; SPRAGUE DAWLEY RAT; SYNTHESIS;

ANIMALS; BRAIN; CARBON RADIOISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROCARBONS, IODINATED; INDOLES; ISOTOPE LABELING; MALE; PIPERIDINES; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031595067     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00021-3     Document Type: Article

References (16)

1. Adger B.M., O'Farrell C., Lewis N.J., Mitchell M.B. Catalytic transfer hydrogenolysis of N-benzyl protecting groups. Synthesis. 1:1987;53-55.
2. 2 antagonists 2. Substituted 3-(4-fluorophenyl)-1H-indoles . J. Med. Chem. 35:1992;4823-4831.
3. 2 receptors in Alzheimer's disease. Brain. 116:1993;497-510.
4. Borch R.F., Bernstein M.D., Durst H.D. The cyanohydridoborate anion as a selective reducing agent. J. Am. Chem. Soc. 93:1971;2897-2904.
5. Cross A.J., Slater P., Perry E.K., Perry R.H. An autoradiographic analysis of serotonin receptors in human temporal cortex Changes in Alzheimer-type dementia . Neurochem. Int. 13:1988;89-96.
6. 11C]methyl iodide. Appl. Radiat. Isot. 38:1987;601-603.
7. Crouzel C., Guillaume M., Barré L., Lemaire C., Pike V.W. Ligands and tracers for PET studies of the 5HT system - Current status. Nucl. Med. Biol. 19:1992;857-870.
8. 2A receptors in schizophrenia. Schizophr. Res. 21:1996;133-139.
9. 2A receptors in the human brain. Eur. J. Nucl. Med. 23:1996;1091.
10. Julian P. L., Oliver J. J., Kimball R. H., Pike A. B. and Jefferson G. D. (1955) α-Phenylacetoacetonitrile. In: Organic Syntheses (Edited by Blatt A. H.), Vol. 2, pp. 487-489. New York: John Wiley.
11. Julian P. L. and Oliver J. J. (1955) α-Phenylacetone from α-Phenylacetoacetonitrile. In: Organic Syntheses (Edited by Blatt A. H.), Vol. 2, pp. 391-393. New York: John Wiley.
12. 2 receptor binding abnormalities in patients with Alzheimer's disease Comparisons with Parkinson's disease . Neurosci. Lett. 51:1984;353-357.
13. Pike V.W. Radioligands for PET studies of central 5-HT receptors and re-uptake sites - Current status. Nucl. Med. Biol. 22:1995;1011-1018.
14. Taguchi K., Westheimer F.H. Catalysis by molecular sieves in the preparation of ketimines and enamines. J. Org. Chem. 36:1971;1570-1572.
15. 3 receptor antagonists Structure-affinity relationships of novel 1,7-annelated indole derivatives . J. Med. Chem. 36:1993;3693-3699.
16. 11C]MDL 100,907. J. Nucl. Med. 37:(suppl.):1996;112P.